LENZ
LENZ Therapeutics Inc
3.90$
+5.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | -586.5% | – | – | -362.4% | |
| – | – | – | 55.6% | – | – | -16.4% | |
| – | – | – | 4.8% | – | – | 65.7% | |
| – | – | – | -48.1% | – | – | 17.0% | |
| – | – | – | 44.0% | – | – | 4.3% | |
| – | – | – | -1,612.4% | – | – | -396.4% | |
| – | – | – | -0.5% | – | – | – | |
| – | – | – | 4.0% | – | – | 784.5% | |
| – | – | – | -2,195.0% | – | – | 25.7% | |
| – | – | – | -630.5% | – | – | -366.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.